Interviews
View More
Cesar Herrera of Yuvo Health is Most Proud of Launching His Company Alongside Partners to Aid Those Without Access of Care

Herrera, chief executive officer and co-founder of Yuvo Health, a technology-enabled administrative and managed-care solution for federally qualified health centers based in New York City, is one of 10 winners in this year's Emerging Industry Leaders series.

Making Time for Self-care, Friends and Family are Key to Avoid Burnout Says Travis Gayles of Hazel Health

Gayles, chief health officer of Hazel Health, a pediatric physical and mental telehealth provider for K-12 schools, headquartered in San Francisco, is one of 10 winners in this year's Emerging Industry Leaders series.

Implications of Multiple Switching with Biologic Therapies

Study-based findings provide support for considerable implications of multiple switching between biosimilar and originator products.

Considerations for Various Vitiligo Treatment Strategies

Dr Rosmarin explores several treatment approaches for vitiligo, including specific options for oral repigmentation treatments.

The One Thing Emily LaFeir Fry of Geisinger Health System Would Change in Healthcare is the Payment Incentives and Model for Financing

LaFeir Fry, vice president of innovation operations at the Geisinger Health System in Danville, Pennsylvania, a regional healthcare provider and health plan, is one of 10 winners in this year's Emerging Industry Leaders series.

Annamaria Macaluso Davidson Says She's Proudest of Herself for Achieving Her Role at of Memorial Hermann Health

Davidson, vice president, employee health medical operations, at Memorial Hermann Health System, in Houston is one of 10 winners in this year's Emerging Industry Leaders series.

The Impact of Unbranded Biologics in the Evolving Treatment Landscape of Autoimmune Disease

Dr Karara provides insight into how unbranded biologics are impacting the overall treatment landscape.

Differentiating Between Unbranded Biologics and Biosimilars

Differences between biologics – both branded and unbranded – and biosimilars are explored by Dr Karara.

Overview of Vitiligo Treatment Landscape

Dr Rosmarin gives a brief overview of treatment pathways.

Official Media Partners

PBMI logo

Join the Community

an mjh life sciences brand

© 2022 MJH Life Sciences and PBMI. All rights reserved.